Growth Metrics

Insulet (PODD) EPS (Basic) (2016 - 2026)

Insulet filings provide 16 years of EPS (Basic) readings, the most recent being $1.44 for Q4 2025.

  • On a quarterly basis, EPS (Basic) changed 0.0% to $1.44 in Q4 2025 year-over-year; TTM through Dec 2025 was $3.5, a 41.47% decrease, with the full-year FY2025 number at $3.51, down 41.21% from a year prior.
  • EPS (Basic) hit $1.44 in Q4 2025 for Insulet, up from $1.24 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $2.69 in Q2 2024 to a low of -$0.5 in Q2 2022.
  • Median EPS (Basic) over the past 5 years was $0.43 (2021), compared with a mean of $0.67.
  • Biggest five-year swings in EPS (Basic): crashed 268.18% in 2021 and later surged 1025.0% in 2023.
  • Insulet's EPS (Basic) stood at $0.43 in 2021, then crashed by 41.86% to $0.25 in 2022, then skyrocketed by 492.0% to $1.48 in 2023, then dropped by 2.7% to $1.44 in 2024, then grew by 0.0% to $1.44 in 2025.
  • The last three reported values for EPS (Basic) were $1.44 (Q4 2025), $1.24 (Q3 2025), and $0.32 (Q2 2025) per Business Quant data.